Spyre Therapeutics (SYRE) Shares Outstanding (Diluted) (2020 - 2026)
Powered by 
Analysis
Spyre Therapeutics (SYRE) Shares Outstanding (Diluted) (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.62 Bn | 131.77 Bn | 2.84 Bn | 255.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.73 Bn | 77.73 Bn | 3.93 Bn | 106.00 Mn |
| 3 | Argenx Se | 63.53 Bn | 58.35 Bn | 1.37 Bn | 66.03 Mn |
| 4 | Moderna | 58.23 Bn | 53.09 Bn | 52.00 Mn | 398.00 Mn |
| 5 | Revolution Medicines | 44.05 Bn | 44.05 Bn | - | 210.89 Mn |
| 6 | BeOne Medicines | 40.03 Bn | 34.93 Bn | 1.53 Bn | 115.80 Mn |
| 7 | Alnylam Pharmaceuticals | 35.50 Bn | 32.19 Bn | 992.69 Mn | 138.28 Mn |
| 8 | Royalty Pharma | 28.52 Bn | 27.68 Bn | - | 556.90 Mn |
| 9 | Insmed | 27.46 Bn | 26.30 Bn | 358.27 Mn | 217.35 Mn |
| 10 | Spyre Therapeutics | 7.35 Bn | 7.35 Bn | - | 85.09 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 85.09 Mn |
| Mar 31, 2026 | 78.91 Mn |
| Dec 31, 2025 | 64.06 Mn |
| Sep 30, 2025 | 60.41 Mn |
| Jun 30, 2025 | 60.33 Mn |
| Mar 31, 2025 | 60.27 Mn |
| Dec 31, 2024 | 47.49 Mn |
| Sep 30, 2024 | 51.25 Mn |
| Jun 30, 2024 | 45.83 Mn |
| Mar 31, 2024 | 37.12 Mn |
| Dec 31, 2023 | 7.34 Mn |
| Sep 30, 2023 | 5.36 Mn |
| Jun 30, 2023 | 154,490.00 |
| Mar 31, 2023 | 3.77 Mn |
| Dec 31, 2022 | 3.37 Mn |
| Sep 30, 2022 | 3.77 Mn |
| Jun 30, 2022 | 3.29 Mn |
| Mar 31, 2022 | 2.64 Mn |
| Dec 31, 2021 | 2.63 Mn |
| Sep 30, 2021 | 2.63 Mn |